Abstract P073: Pharmacological inhibition of IRAK4 with CA-4948 is beneficial in marginal zone lymphoma models with secondary resistance to PI3K and BTK inhibitors
F. Guidetti, A. Arribas, F. Spriano, L. Barnabei, R. V. von Roemeling, E. Martinez, E. Zucca, F. Bertoni
{"title":"Abstract P073: Pharmacological inhibition of IRAK4 with CA-4948 is beneficial in marginal zone lymphoma models with secondary resistance to PI3K and BTK inhibitors","authors":"F. Guidetti, A. Arribas, F. Spriano, L. Barnabei, R. V. von Roemeling, E. Martinez, E. Zucca, F. Bertoni","doi":"10.1158/1535-7163.targ-21-p073","DOIUrl":null,"url":null,"abstract":"Francesca Guidetti 1, Alberto J. Arribas 1,2, Filippo Spriano 1, Laura Barnabei 1, Reinhard von Roemeling 3, Elizabeth Martinez 3, Emanuele Zucca 1,4, Francesco Bertoni 1,4 1 Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland; 2 SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland; 3 Curis, Inc, Lexington, MA, USA; 4 Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.","PeriodicalId":20348,"journal":{"name":"Poster Presentations - Proffered Abstracts","volume":"40 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Poster Presentations - Proffered Abstracts","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1158/1535-7163.targ-21-p073","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Francesca Guidetti 1, Alberto J. Arribas 1,2, Filippo Spriano 1, Laura Barnabei 1, Reinhard von Roemeling 3, Elizabeth Martinez 3, Emanuele Zucca 1,4, Francesco Bertoni 1,4 1 Institute of Oncology Research, Faculty of Biomedical Sciences, USI, Bellinzona, Switzerland; 2 SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland; 3 Curis, Inc, Lexington, MA, USA; 4 Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
